XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,027,030 | -9.8% | 28,696 | -0.7% | 0.13% | -24.0% |
| Q4 2022 | $1,139,014 | +9.6% | 28,887 | +0.3% | 0.18% | -20.1% |
| Q3 2022 | $1,039,000 | -80.5% | 28,792 | -83.5% | 0.22% | -83.9% |
| Q2 2022 | $5,324,000 | -64.0% | 175,000 | -63.8% | 1.36% | -71.6% |
| Q1 2022 | $14,774,000 | -29.4% | 483,270 | -27.9% | 4.79% | -57.2% |
| Q4 2021 | $20,934,000 | – | 670,093 | – | 11.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |